The radiation oncology experts at OHC are using advanced technology to destroy cancerous brain tumors and give patients an improved chance at a longer remission. In the past, brain tumors were treated with radiation to the entire brain. This resulted... Read More

OHC doctors share preliminary results of a national study on extended use of immunotherapy for advanced non-small cell lung cancer

David M. Waterhouse, MD, MPH, medical oncologist, hematologist and co-director of the department of clinical research at OHC

The Journal of Clinical Oncology published an article in its November 2020 issue about a study evaluating the extended use of nivolumab (Opdivo) for certain patients with advanced non-small cell lung cancer (NSCLC). As the lead author of the study, I... Read More

Two Years After its Introduction, Ground-breaking Cancer Treatment CAR-T is Showing Positive Results

E. Randolph Broun, MD, a noted medical oncologist, hematologist and blood and marrow transplant specialist

Two years ago, the cancer experts at OHC were the first independent adult cancer group in the region to introduce the revolutionary treatment, CAR T-cell therapy, for adults. Since that noteworthy day, our researchers have made some great strides in... Read More

A Message of Thanks to Our Patients, Their Families and Our Community

the Doctors and Staff at OHC

At OHC, we want to acknowledge the kindness and contributions of our patients, their families and the community during the COVID-19 pandemic. Your outpouring of support, especially during the initial height and current spike of the virus, has served... Read More

Cancer and COVID-19: Celebrate Safe Holidays This Season

Prasad R. Kudalkar, MD, medical oncologist and hematologist

As COVID screenings increase and positive results trend up, families are faced with difficult decisions about how to safely navigate the holiday season. Those with weakened immune systems, including many cancer patients, are more susceptible to... Read More

Treatment advancements and awareness are giving patients with pancreatic cancer hope

Evan Z. Lang, MD, MS, medical oncologist and hematologist who specializes in the treatment of pancreatic cancer

November is Pancreatic Cancer Awareness Month and the cancer experts at OHC believe the more you know about the disease – including risks, symptoms and early detection – as well as advancements in treatments, the better the chance for extended... Read More

Gifts allow breast cancer patients to focus on fun

D. Randolph Drosick, MD, a medical oncologist and hematologist at OHC who serves on the Karen Wellington Foundation Medical Advisory Board

For women dealing with breast cancer their lives tend to be consumed by their disease and treatment. At OHC, our team leads patients through their cancer journey with advanced treatments as well as support services and resources to help them manage... Read More

New FDA-approved treatment for lung cancer is available at OHC

Benjamin T. Herms, MD, OHC medical oncologist and hematologist who specializes in lung and genitourinary cancer

OHC is excited to share that the US Food and Drug Administration has approved a new treatment for metastatic non-small cell lung cancer. This new treatment, which has been available at OHC since April through its clinical trials, offers these... Read More

Finding Healing Through Art

Rebecca Hendrixson

Written by Rebecca Hendrixson and photographed by Robert White for Venue magazine. In the spring of 2017, during a routine checkup, Samantha England’s gynecologist found a lump in her left breast. A biopsy was performed, and results came back... Read More

OHC is evaluating a promising new treatment for metastatic HER2-positive breast cancer

Paula Weisenberger, MD, Medical Oncologist and Hematologist at OHC

One of every five breast cancers are HER2-positive breast cancers. This type tends to grow and spread faster than other breast cancers but are much more likely to respond to treatments that target the HER2 protein. A recent study reported that women... Read More